# The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care

Study · id `cardio:ct-nct03649516` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03649516](<https://clinicaltrials.gov/study/NCT03649516>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03649516

Browse, organ or system: Blood vessels; Kidneys  
Browse, condition area: High blood pressure; Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

## Technical summary

Registry record NCT03649516. Randomized; no masking; primary purpose supportive care. Start 2018-06-26 (actual); primary completion 2020-08-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 101 participants (enrolled count; ClinicalTrials.gov record NCT03649516, source copy `cardio:ctgov-nct03649516-2021-09-02`, retrieved 2026-10-26)
- Started: 2018-06-26 (actual) (ClinicalTrials.gov record NCT03649516, source copy `cardio:ctgov-nct03649516-2021-09-02`, retrieved 2026-10-26)
- Primary completion: 2020-08-31 (actual) (ClinicalTrials.gov record NCT03649516, source copy `cardio:ctgov-nct03649516-2021-09-02`, retrieved 2026-10-26)
- Completion: 2020-08-31 (actual) (ClinicalTrials.gov record NCT03649516, source copy `cardio:ctgov-nct03649516-2021-09-02`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT03649516, source copy `cardio:ctgov-nct03649516-2021-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03649516-2021-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care
- Condition: Chronic Kidney Disease
- Condition: Hypertension
- Intervention (Device): iCKD APP
- Lead sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital (`cardio:org-kaohsiung-medical-university-chung-ho-memorial-hospital`)

## Provenance

Content hash: 891dd62c61e972520c02d928fefea398ba8a7615dc837c782a452e8e898e38e3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
